VEGFR2/CD309 antibody
Quick Overview for VEGFR2/CD309 antibody (ABIN2477091)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Characteristics
- Purified IgG
-
Purification
- Purified
-
Immunogen
- Synthetic peptide: internal domain of human VEGF receptor 2, conjugated to Keyhole Limpet Hemocyanin (KLH).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
-
-
: "Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis." in: Journal of biochemistry and molecular biology, Vol. 39, Issue 5, pp. 469-78, (2006) (PubMed).
-
: "Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis." in: Journal of biochemistry and molecular biology, Vol. 39, Issue 5, pp. 469-78, (2006) (PubMed).
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- VEGF RECEPTOR 2
-
Background
- Synonyms: KDR
-
Gene ID
- 3791
-
UniProt
- P35968
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-